Oarsman Capital’s Patterson-UTI PTEN Stock Holding History

Oarsman Capital’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,850	Closed	-$164K	–	253
2025 Q4	$164K	Hold	26,850	–	–	0.02%	238
2025 Q3	$139K	Buy	+26,850	New	+$154K	0.02%	247

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Oarsman Capital's PTEN Position: Q1 2026 in Review

Oarsman Capital sold out of Patterson-UTI (PTEN) in Q1 2026, closing a stake of 26,850 shares — an estimated $164K sold.

Oarsman Capital first reported a position in PTEN in Q3 2025 and held it in 2 quarters. The position peaked at $164K in Q4 2025. 414 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

Oarsman Capital reported no remaining Patterson-UTI position as of Q1 2026 after selling out during the quarter.
Oarsman Capital sold 26,850 Patterson-UTI shares in Q1 2026, an estimated $164K.
Oarsman Capital first reported a position in Patterson-UTI in Q3 2025 and held it in 2 quarters.
Oarsman Capital's Patterson-UTI position peaked at $164K in Q4 2025.
414 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Oarsman Capital's 13F filing for Q1 2026, filed 28 Apr 2026.